Nabriva’s pneumonia drug succeeds in late-stage trial Analysts, Antibiotics, Clinical Trials, Community-Acquired Bacterial Pneumonia (CAPB), Pleuromutilins, R&D, Shares Nabriva Therapeutics’ experimental antibiotic lefamulin for CABP met the main goal of a late-stage study. Read more September 18, 2017/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2017-09-18 07:49:142017-09-18 13:30:35Nabriva's pneumonia drug succeeds in late-stage trial
